Cargando…

Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma

BACKGROUND: The identification and validation of suitable predictive and prognostic factors are a challenge to improve the treatment scheme selection. Discordances in histological grade can be established between core biopsy and surgical specimens. This is important in HR-positive/HER2-negative subg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daveau, C, Baulies, S, Lalloum, M, Bollet, M, Sigal-Zafrani, B, Sastre, X, Vincent-Salomon, A, Tardivon, A, Thibault, F, Pierga, J Y, Cottu, P, Sablin, M P, Rouzier, R, Malhaire, C, Mallon, P, Reyal, F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007232/ https://www.ncbi.nlm.nih.gov/pubmed/24714751 http://dx.doi.org/10.1038/bjc.2014.143

Ejemplares similares

Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy
por: Baulies, S, et al.
Publicado: (2015)

Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2012)

Correction: Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2012)

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay
por: Mouttet, D., et al.
Publicado: (2016)

Skin Lesions after Prophylactic Mastectomy and Immediate Reconstruction
por: Baulies, Sonia, et al.
Publicado: (2014)

Evaluating tumour response to primary radiochemotherapy in breast cancer patients: what role for breast magnetic resonance imaging?
por: Thibault, F, et al.
Publicado: (2008)

The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2011)

Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models
por: Laas, E, et al.
Publicado: (2015)

Long-Term Prognostic Performance of Ki67 Rate in Early Stage, pT1-pT2, pN0, Invasive Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2013)

Are ipsilateral breast tumour invasive recurrences in young (⩽40 years) women more aggressive than their primary tumours?
por: Sigal-Zafrani, B, et al.
Publicado: (2007)

Bilateral Poly Implant Prothèse Implant Rupture: An Uncommon Presentation
por: Mallon, Peter, et al.
Publicado: (2013)

Low Concordance between Gene Expression Signatures in ER Positive HER2 Negative Breast Carcinoma Could Impair Their Clinical Application
por: Laas, Enora, et al.
Publicado: (2016)

Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2015)

External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement
por: Hajage, David, et al.
Publicado: (2011)

Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2017)

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma
por: Rossi, L, et al.
Publicado: (2015)

HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?
por: Vincent-Salomon, A, et al.
Publicado: (2007)

Non-Sentinel Lymph Node Metastasis Prediction in Breast Cancer with Metastatic Sentinel Lymph Node: Impact of Molecular Subtypes Classification
por: Reyal, Fabien, et al.
Publicado: (2012)

Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2016)

High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies
por: Bollet, M A, et al.
Publicado: (2008)

Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
por: Hamy, Anne-Sophie, et al.
Publicado: (2018)

Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
por: Hamy-Petit, Anne-Sophie, et al.
Publicado: (2016)

Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance
por: Choesmel, Valérie, et al.
Publicado: (2004)

Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery
por: Gosset, Marie, et al.
Publicado: (2016)

Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment
por: Bollet, Marc A, et al.
Publicado: (2009)

Impact de l’épidémie de COVID-19 sur les demandes de prise en charge initiale pour cancer du sein
por: Héquet, Delphine, et al.
Publicado: (2020)

Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World Population
por: Rossi, Lea, et al.
Publicado: (2015)

Genomic Instability: A Stronger Prognostic Marker Than Proliferation for Early Stage Luminal Breast Carcinomas
por: Vincent-Salomon, Anne, et al.
Publicado: (2013)

Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial
por: Jacot, William, et al.
Publicado: (2019)

Correspondence and Concordance of Retrospective and Concurrent Responses to Physiotherapists and Sport Psychology Questionnaire Items
por: Groover, Ashlee E., et al.
Publicado: (2022)

Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer
por: Porte, B., et al.
Publicado: (2020)

Hyperechoic breast images: all that glitters is not gold!
por: Journo, Gabrielle, et al.
Publicado: (2018)

The Composition and Concordance of Lactobacillus Populations of Infant Gut and the Corresponding Breast-Milk and Maternal Gut
por: Zhang, Xuyao, et al.
Publicado: (2020)

Epigenomic Alterations in Breast Carcinoma from Primary Tumor to Locoregional Recurrences
por: Moarii, Matahi, et al.
Publicado: (2014)

Concordant Signaling Pathways Produced by Pesticide Exposure in Mice Correspond to Pathways Identified in Human Parkinson's Disease
por: Gollamudi, Seema, et al.
Publicado: (2012)

Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation
por: de Plater, L, et al.
Publicado: (2010)

HR Explorer
por: Möller, M, et al.
Publicado: (1997)

KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer
por: Jo, Peter, et al.
Publicado: (2020)

Correspondence
por: Bennett, P. M.
Publicado: (1969)

Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach
por: Laas, Enora, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k37qa039kjo70blcgf5kf2v7cv